IN2014DN07767A - - Google Patents
Info
- Publication number
- IN2014DN07767A IN2014DN07767A IN7767DEN2014A IN2014DN07767A IN 2014DN07767 A IN2014DN07767 A IN 2014DN07767A IN 7767DEN2014 A IN7767DEN2014 A IN 7767DEN2014A IN 2014DN07767 A IN2014DN07767 A IN 2014DN07767A
- Authority
- IN
- India
- Prior art keywords
- amino
- salt
- polyoxyethylene sorbitan
- sorbitan fatty
- fatty acid
- Prior art date
Links
- 229920001214 Polysorbate 60 Polymers 0.000 abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 2
- 229930195729 fatty acid Natural products 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 abstract 2
- -1 fatty acid ester Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 229960000686 benzalkonium chloride Drugs 0.000 abstract 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 abstract 1
- ZBPLOVFIXSTCRZ-UHFFFAOYSA-N bromfenac Chemical compound NC1=C(CC(O)=O)C=CC=C1C(=O)C1=CC=C(Br)C=C1 ZBPLOVFIXSTCRZ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012073181 | 2012-03-28 | ||
| PCT/JP2013/059211 WO2013147000A1 (ja) | 2012-03-28 | 2013-03-28 | ２－アミノ－３－（４－ブロモベンゾイル）フェニル酢酸含有水性組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN07767A true IN2014DN07767A (enExample) | 2015-05-15 |
Family
ID=49260248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN7767DEN2014 IN2014DN07767A (enExample) | 2012-03-28 | 2013-03-28 |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JP5922609B2 (enExample) |
| KR (1) | KR20140139501A (enExample) |
| CN (1) | CN104203224A (enExample) |
| IN (1) | IN2014DN07767A (enExample) |
| MY (1) | MY170840A (enExample) |
| PH (1) | PH12014502171A1 (enExample) |
| SG (1) | SG11201405837YA (enExample) |
| TW (1) | TWI604858B (enExample) |
| WO (1) | WO2013147000A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017002042A (ja) * | 2015-06-10 | 2017-01-05 | 参天製薬株式会社 | 点眼剤、及び点眼剤防腐効力維持方法 |
| KR20200099547A (ko) * | 2017-12-14 | 2020-08-24 | 산텐 세이야꾸 가부시키가이샤 | 2-아미노-3-(4-브로모벤조일)페닐아세트산 또는 그의 염을 함유하는 점안제 |
| CN114224830A (zh) * | 2021-12-24 | 2022-03-25 | 辰欣药业股份有限公司 | 一种单剂量无抑菌剂的眼用制剂及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002308764A (ja) * | 2001-02-09 | 2002-10-23 | Taisho Pharmaceut Co Ltd | 眼科用医薬組成物 |
| ES2381672T3 (es) * | 2003-11-14 | 2012-05-30 | Senju Pharmaceutical Co., Ltd. | Preparación en solución acuosa que comprende un antibiótico aminoglicósido y bromfenaco |
| CN1823754A (zh) * | 2006-03-28 | 2006-08-30 | 卢秀莲 | 溴芬酸钠滴眼液及其制备方法 |
| CN101313899B (zh) * | 2007-06-01 | 2012-02-29 | 北京德众万全药物技术开发有限公司 | 一种含有溴芬酸钠的眼用药物组合物 |
| CA2716110A1 (en) * | 2008-02-21 | 2009-08-27 | Tim Mcnamara | Ophthalmic nsaids as adjuvants |
| CN101322683B (zh) * | 2008-07-30 | 2013-01-16 | 浙江三叶药业有限公司 | 一种含有溴芬酸钠水合物的眼用凝胶剂及其制备方法 |
| KR102075173B1 (ko) * | 2011-01-18 | 2020-02-07 | 센주 세이야꾸 가부시키가이샤 | 보존 효력을 갖는 브롬페낙 수성 액제 조성물 |
| JP6012231B2 (ja) * | 2011-04-08 | 2016-10-25 | ロート製薬株式会社 | ブロムフェナク含有組成物 |
-
2013
- 2013-03-27 TW TW102110918A patent/TWI604858B/zh not_active IP Right Cessation
- 2013-03-28 KR KR1020147025807A patent/KR20140139501A/ko not_active Abandoned
- 2013-03-28 CN CN201380014630.8A patent/CN104203224A/zh active Pending
- 2013-03-28 SG SG11201405837YA patent/SG11201405837YA/en unknown
- 2013-03-28 WO PCT/JP2013/059211 patent/WO2013147000A1/ja not_active Ceased
- 2013-03-28 JP JP2013068407A patent/JP5922609B2/ja not_active Expired - Fee Related
- 2013-03-28 IN IN7767DEN2014 patent/IN2014DN07767A/en unknown
- 2013-03-28 MY MYPI2014702590A patent/MY170840A/en unknown
-
2014
- 2014-09-26 PH PH12014502171A patent/PH12014502171A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP5922609B2 (ja) | 2016-05-24 |
| JP2013227300A (ja) | 2013-11-07 |
| PH12014502171A1 (en) | 2014-12-10 |
| MY170840A (en) | 2019-09-10 |
| TW201343197A (zh) | 2013-11-01 |
| SG11201405837YA (en) | 2014-11-27 |
| CN104203224A (zh) | 2014-12-10 |
| KR20140139501A (ko) | 2014-12-05 |
| TWI604858B (zh) | 2017-11-11 |
| WO2013147000A1 (ja) | 2013-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201390074A1 (ru) | 5-хлор-4-гидрокси-1-метил-2-оксо-n-фенил-1,2-дигидрохинолин-3-карбоксамид, его соли и применения | |
| PH12015502031A1 (en) | Tetrahydropyrrolothiazine compounds | |
| UY34763A (es) | Inhibidores de la agregación plaquetaria | |
| HK1210696A1 (en) | Irak inhibitors and uses thereof | |
| MX2016003843A (es) | Inhibidores de cinasas asociadas al receptor de interleucina 1 (irak) y usos de los mismos. | |
| BR112015022763A2 (pt) | sensores de oxigênio | |
| EP3046932A4 (en) | Evolved sortases and uses thereof | |
| MA39095A1 (fr) | Anticorps et immunoconjugués anti-cd33 | |
| PH12013500246A1 (en) | Besylate salt of a btk inhibitor | |
| MX351513B (es) | Compuesto de alquinilbenceno 3,5-disustituido y sales del mismo. | |
| HK1216859A1 (zh) | Irak抑制劑和其用途 | |
| UY34608A (es) | Péptidos sintéticos de tránsito al cloroplasto. | |
| MX2015015417A (es) | Inhibidores de acetil-coa carboxilasa (acc) y usos de los mismos. | |
| EA201690911A1 (ru) | Соединения диметилбензойной кислоты | |
| MX2015011837A (es) | Co-cristale de pirimetanil y tetracarboximida de ditiina seleccionada. | |
| CA2875305C (en) | Fbxo3 inhibitors | |
| HK1222848A1 (zh) | 用作alk抑制剂的吡咯并三嗪 | |
| AU2014224814A8 (en) | Novel halogen-substituted compounds | |
| UA115072C2 (uk) | Похідні гідантоїну | |
| IN2014DN07767A (enExample) | ||
| PH12014501840A1 (en) | Pharmaceutical formulation having improved stability | |
| CL2015002350A1 (es) | Composición agroquimica en suspensión acuosa | |
| EP2992086A4 (en) | MODULATION OF THE FUNCTION OF REGULATORY T CELLS USING PROTEIN KINASE-C-ETA | |
| WO2014105777A8 (en) | Cobicostat dichlohydrate salt | |
| MY175703A (en) | Tablets with improved acceptance and good storage stability |